List of works by K. Rajender Reddy

A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis

scientific article published on 24 October 2016

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

scientific article published in PLoS ONE

A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be.

scientific article

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype

scientific article published in November 2000

A phase I study of chemoembolization with cisplatin and lipiodol for primary and metastatic liver cancer

scientific article published on October 1994

A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C.

scientific article published on 17 January 2012

A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection

scientific article

A sibship with hypervalinemia

scientific article published on 01 November 1977

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

scientific article published on 4 May 2014

ACG clinical guideline: the diagnosis and management of focal liver lesions

article by Jorge A Marrero et al published September 2014 in The American Journal of Gastroenterology

Acetaminophen-related hepatotoxicity

scientific article published on 04 September 2013

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes

scientific article published on 25 April 2017

Acute Liver Failure.

scientific article published on 29 July 2017

Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation

scientific article published on 7 July 2005

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin

scientific article published on 26 May 2013

Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

scientific article

All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database

scientific article published on 28 October 2016

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy

scientific article

An Immunoassay to Rapidly Measure Acetaminophen Protein Adducts Accurately Identifies Patients With Acute Liver Injury or Failure

scientific article published on 15 September 2016

An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon

scientific article published in December 2001

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

scientific article published on 11 February 2013

Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin

scientific article published on 4 April 2007

Bacterial infections in end-stage liver disease: current challenges and future directions

scientific article published on 3 June 2012

Benign Lesions of the Liver

scientific article published on May 2006

Biologic and clinical features of benign solid and cystic lesions of the liver

scientific article published on 11 March 2011

Boceprevir for untreated chronic HCV genotype 1 infection

scientific article (publication date: 31 March 2011)

Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response

scientific article published on May 2014

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

scientific article

Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories

scientific article published on 20 January 2017

Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States

scientific article published in January 2015

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Hea

scientific article published on June 2013

Clinical features and natural history of hepatocellular adenomas: the impact of obesity.

scientific article published on 15 July 2011

Clinical outcomes of liver transplantation for HBV‐related hepatocellular carcinoma: data from the NIH HBV OLT study ⬇️

scientific article published on November 16, 2010

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis

scientific article

Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management

scientific article

Coagulopathy in liver disease

scientific article

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

scientific article published in April 2008

Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma

scientific article published in March 2007

Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice

scientific article published in May 2003

Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

scientific article published on 24 November 2014

Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis

scientific article published on August 2007

Current trends in living donor liver transplantation for primary sclerosing cholangitis

scientific article

Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.

scientific article published on 27 February 2018

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

scientific article (publication date: 16 January 2014)

Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury

scientific article

Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1

scientific article published on 31 May 2018

Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States

scientific article published on 30 September 2015

Developing strategies for prevention and treatment of recurrent HBV in liver transplantation

scientific article published in February 1999

Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).

scientific article published in January 2004

Diagnosis and management of overlap syndromes

scientific article

Diagnostic laparoscopy: a 5-year experience in a hepatology training program

scientific article published on August 1, 1995

Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

scientific article published on 24 August 2011

Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.

scientific article published on 29 November 2006

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance

scientific article published on 05 April 2016

Doctor Griffin Rodgers at helm of the National Institute of Diabetes and Digestive and Kidney Diseases

scientific article published in August 2007

Donation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?

scientific article published in June 2011

Drug Hepatotoxicity: Newer Agents

scientific article published on 14 October 2016

Drug-induced liver injury due to cancer chemotherapeutic agents

scientific article published on 31 May 2014

ERCP documentation of obstructive jaundice caused by a solitary, centrally located, benign hepatic cyst.

scientific article

Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group

scientific article published on November 1998

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

scientific article published in May 2006

Effect of kidney transplantation on outcomes among patients with hepatitis C

scientific article

Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial

scientific article published on July 2012

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

scientific article published on 21 October 2015

Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates

scientific article published on 30 March 2007

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial

scientific article published on 4 August 2013

Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial

scientific article published in July 2004

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

scientific article

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial

scientific article published on 30 July 2016

Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre-existing renal disease

scientific article published on 23 March 2017

Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension

scientific article published on 26 November 2018

Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study

scientific article published on 28 October 2015

Evaluation of nonmalignant liver masses

scientific article

Experience with staging laparoscopy in pancreatic malignancy

scientific article published in April 1999

Extrahepatic manifestations of chronic viral hepatitis

scientific article

Factors that influence the severity of recurrent hepatitis c virus following liver transplantation ⬇️

scientific article published on August 1, 2003

Factors that predict short-term intensive care unit mortality in patients with cirrhosis

scientific article published on 16 April 2013

Familial incidence of L-xylulosuria

scientific article published on 01 November 1977

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

scientific article published on March 2007

First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline

scientific article published in September 2002

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

scientific article published on May 2015

Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience

scientific article published on 26 December 2016

Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial

scientific article

HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death

scientific article

HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape

scientific article

HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary

scientific article published on 5 December 2017

HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome

scientific article published in April 2014

Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures

scientific article

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study

scientific article

Hepatic dysfunction accompanying acute cocaine intoxication.

scientific article published in May 1991

Hepatic encephalopathy and orotic aciduria associated with hepatocellular carcinoma in a noncirrhotic liver

scientific article published on 01 January 1988

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin

scientific article published in February 2008

Hepatitis B and C in African Americans: current status and continued challenges

scientific article published on 28 June 2013

Hepatitis C infection in two urban hemodialysis units

scientific article

Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options

scientific article

Hepatitis C virus infection and hepatocellular carcinoma

scientific article published on August 2008

Hepatitis C virus infection and immunomodulatory therapies

scientific article published on August 2009

Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country

scientific article

Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate

scientific article published on 16 August 2010

Hepatitis C virus-infected donors in liver transplantation

scientific article published in August 2007

Hepatitis C virus. Preface

scientific article published on August 2008

Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated

scientific article published on June 2004

Hepatitis C-associated hepatocellular carcinoma

scientific article published on 01 September 1990

Hepatitis C: Unfolding the Challenges

scientific article published on December 2015

Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C.

scientific article published on 25 January 2016

Hepatitis and augmentin

scientific article published on 01 August 1990

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

scientific article published in January 1997

Hepatotoxicity after prolonged use of acetaminophen: a case report

scientific article published in November 1988

Hepatotoxicity of hypolipidemic drugs

scientific article

High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease

scientific article published on July 2015

Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection

scientific article

Hypercoagulation and thrombophilia in liver disease

scientific article

Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset

scientific article

Immune dysfunction and infections in patients with cirrhosis

scientific article published on 11 March 2011

Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometry ⬇️

scientific article published on 01 July 1991

Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection

scientific article published on January 2011

Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort

scientific article

Impact of oral silymarin on virus- and non-virus-specific T-cell responses in chronic hepatitis C infection

scientific article published on 12 April 2013

Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment

scientific article published on 28 December 2006

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation

scientific article

Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase

scientific article

Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy

scientific article published in March 2007

Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads ⬇️

scientific article published on September 30, 2010

Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C.

scientific article published in September 2002

Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population

scientific article published on October 2004

Interferon-induced chronic active hepatitis? ⬇️

scientific article published on September 1, 1991

Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy

scientific article published in May 2005

Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients

scientific article published on 6 March 2017

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

scientific article

Laparoscopic and histologic findings in patients with the human immunodeficiency virus.

scientific article published in March 1994

Laparoscopic evaluation of liver disease in chronic renal failure prior to renal transplantation

scientific article published on June 1997

Laparoscopic observations of the liver in hereditary hemorrhagic telangiectasia

scientific article

Laparoscopically directed fine needle aspiration for the diagnosis of hepatocellular carcinoma: a safe and accurate technique

scientific article published on May 1988

Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center

scientific article

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

scientific article published on 15 May 2015

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

scientific article (publication date: 15 May 2014)

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

scientific article (publication date: 17 April 2014)

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

scientific article published on 9 May 2015

Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

scientific article published on 25 January 2017

Let's Make a Deal: Shortening the Solid Organ Transplant Waiting Time in Exchange for Transmitting and Treating Hepatitis C Infection in the Era of Safe and Effective Directly Acting Antivirals

scientific article published on 4 September 2017

Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir? Authors' reply

scientific article published in May 2016

Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network

scientific article

Liver transplantation and cirrhotomimetic hepatocellular carcinoma: classification and outcomes

scientific article

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome

scientific article published in July 2004

Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature

scientific article

Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data

scientific article

Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

scientific article published on 21 September 2017

Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis

scientific article

Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances

scientific article published on 15 June 2014

Management of hepatitis C virus in special populations: patient and treatment considerations

scientific article

NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection.

scientific article

New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection

scientific article published on 30 August 2013

No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients

scientific article published on 09 August 2018

Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

scientific article

Noncirrhotic portal hypertension

scientific article

Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.

scientific article published in October 2009

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

scientific article published on 31 March 2015

On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial

scientific article

One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy

scientific article

Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin

scientific article published on 14 May 2012

Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status

scientific article

Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list

scientific article published on January 2005

Outcomes after liver transplantation: chronic kidney disease

scientific article published in November 2009

Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study

scientific article

Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation

scientific article

Outcomes in pediatric hepatitis C transplant recipients: analysis of the UNOS database

scientific article published on 11 December 2014

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

scientific article published on 9 October 2013

Pathogenesis of liver injury in acute liver failure

scientific article published on 13 July 2012

Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment

scientific article published on 22 March 2017

Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir

scientific article published on 16 November 2017

Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria

scientific article published on 10 January 2018

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

scientific article published in June 2004

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

scientific article published in December 2004

Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

scientific article

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

scientific article (publication date: 26 September 2002)

Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients

scientific article published on October 2009

Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients

scientific article published on 17 March 2014

Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis

scientific article published on 7 March 2008

Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line

scientific article

Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury

scientific article published on 8 September 2015

Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system

scientific article published on 28 February 2015

Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation

scientific article published in January 2006

Post liver biopsy hemobilia in a cirrhotic patient with portal hypertension and varices: the diagnostic role of ERCP

scientific article published on 01 June 1986

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes

scientific article published on 31 July 2017

Postoperative jaundice

scientific article 1999

Postoperative jaundice as a clue to unrecognized biliary tract obstruction

scientific article published on 01 December 1987

Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

scientific article

Predicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatment

scientific article

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

scientific article published in September 2005

Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort.

scientific article published on 19 December 2017

Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease

scientific article published in August 2002

Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.

scientific article

Prevalence of anti-HIV and anti-delta among deferred HBsAg-positive volunteer blood donors

scientific article published on 01 August 1987

Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance

scientific article (publication date: 2013)

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

scientific article published in October 2002

Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in Hepatitis C Therapy): A Nurse-Driven Evidence-Based Protocol

scientific article

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease

scientific article published in January 2006

Pruritus in chronic cholestatic liver disease

scientific article published on May 2012

Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy

scientific article

Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States

scientific article published on 23 June 2009

Racial difference in mortality among U.S. veterans with HCV/HIV coinfection

scientific article published on 22 February 2006

Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C.

scientific article published on 26 June 2013

Rapid virologic response: a new milestone in the management of chronic hepatitis C.

scientific article published on January 2008

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C

scientific article published on 4 November 2011

Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial

scientific article published on April 2009

Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.

scientific article published on January 2005

Recurrence of diseases following orthotopic liver transplantation

scientific article published on June 2006

Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN).

scientific article

Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation

scientific article published in September 2005

Resection of metachronous hepatocellular carcinomas

scientific article published on 01 December 1986

Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

scientific article published in October 1986

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.

scientific article published on 17 October 2011

Response-guided and -unguided treatment of chronic hepatitis C.

scientific article published on February 2012

Review article: herbal and dietary supplement hepatotoxicity

scientific article

Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection

scientific article published on 27 May 2015

Review article: the evaluation of solitary liver masses

scientific article published on 16 July 2008

Review article: the evolving role of liver biopsy

scientific article published in August 2004

Ribavirin considerations in treatment optimization.

scientific article published on January 2008

Ribavirin: current role in the optimal clinical management of chronic hepatitis C.

scientific article published on 03 December 2008

Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes

scientific article published on August 2003

Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model

scientific article

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status

scientific article

Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis

scientific article published on March 2013

Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy

scientific article published on 06 April 2015

Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study

scientific article published on 15 May 2017

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

scientific article

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

scientific article published on June 2015

Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

scientific article published on 05 July 2012

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

scientific article

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

scientific article published on 4 September 2012

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

scientific article

Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience

scientific article

Serum apoptosis markers in acute liver failure: a pilot study.

scientific article published on 29 October 2007

Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid

scientific article published in December 2004

Severe liver injury

scientific article

Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C

scientific article

Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial

scientific article published on 5 December 2014

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial

scientific article

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

scientific article

Sofosbuvir for previously untreated chronic hepatitis C infection

scientific article (publication date: 16 May 2013)

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

scientific article

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

scientific article published on June 2017

Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection

scientific article published on March 2013

Sofosbuvir-ledipasvir with or without ribavirin for chronic hepatitis C genotypes 1 and 6: real-world experience in Vietnam

scientific article published on 5 January 2017

Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations

scientific article published on 2 December 2011

Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy

scientific article published on April 2007

Supplements and Hepatotoxicity

scientific article published on July 2015

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures

scientific article

Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity

scientific article published on April 2015

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.

scientific article published in June 2005

T1ρ MRI of healthy and fibrotic human livers at 1.5 T.

scientific article

Telaprevir for previously untreated chronic hepatitis C virus infection

scientific article (publication date: 23 June 2011)

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series

scientific article published on 29 April 2012

The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

scientific article published on 21 December 2015

The Natural History of Severe Acute Liver Injury

scientific article published on 25 April 2017

The Need for Appropriate Comparisons: A Response to Ravi et al

scientific article published in June 2017

The North American Study for the Treatment of Refractory Ascites

scientific article

The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection

scientific article

The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease

scientific article

The role of laparoscopy in the diagnosis of cirrhosis

scientific article published on June 1996

The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients

scientific article published in January 2003

The unusual presentation of "large" gallstones. The diagnostic role of endoscopy

scientific article published on 01 April 1986

The use of macrophyte-based systems for phosphorus removal: an overview of 25 years of research and operational results in Florida

scientific article

Transjugular intrahepatic portosystemic shunts in liver transplant recipients

scientific article published on 12 December 2013

Transplantation for chronic hepatitis B and C: strategies for prevention and treatment of recurrent disease.

scientific article

Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy

scientific article published on 28 March 2016

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

scientific article published on September 1997

Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation

scientific article published on 31 July 2013

Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients

scientific article published on 30 April 2017

Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial

scientific article published on 07 August 2018

Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers

scientific article published on July 2013

Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts

scientific article published on April 2009

Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine ⬇️

scientific article published on April 27, 2003

Use of peginterferon alfa-2a (40 KD) (Pegasys) for the treatment of hepatitis C.

scientific article

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma

scientific article

Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database

scientific article

Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.

scientific article published on 25 January 2006

Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study

scientific article

Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.

scientific article

Paulina is supported by:

About Paulina

Help